Community Engagement and Outreach

特拉华州在临床和转化科学研究和教育方面具有非凡的合作和综合方法。DE-CTR的社区参与和外联（CEO）部分将创建基础设施、流程和网络，使全州广泛和多样化的社区参与基于实践和基于社区的转化研究。在这样做的同时，它还将为在临床和转化科学研究、教育和支持方面整合多种发展中的全州健康促进和疾病预防活动建立支柱。此外，它将纳入创新的卫生信息技术，用于卫生传播和社会营销，从而在全国范围内开展互动式研究参与、学习、招聘和传播活动。CEO还将与南卡罗来纳州临床和转化研究所（SCTR）的社区研究工作合作，以加强CEO的发展，并促进对南卡罗来纳州和更广泛的科学界的研究互动传播。医学研究所（lOM）的报告。跨越质量鸿沟，呼吁开展一项重大运动，以发现在国家、区域、州和地方各级社会改善健康和缩小健康差距的有效方法。随后的lOM报告强调了加速肥胖预防进展和探索整合以改善人口健康的必要性，以促进健康行为并更好地影响我们不同社区的成员。这些行动呼吁在特拉华州引起共鸣，该州面临着减轻与相对高水平的慢性疾病和残疾相关的人类影响和经济成本的挑战。有效应对这一挑战需要将临床研究成果转化为社区和临床实践环境，以满足不同人群的需求。DE-CTR机构将通过让社区组织及其代表、卫生保健提供者、临床实践和机构调查人员参与制定、实施和评估旨在改善该区域人口健康的转化研究举措来推进这一议程。首席执行官组成部分是DE-CTR的一个核心方面，它将为社区组织、初级保健实践、不同人群、全州活动和DECTR调查员参与临床和转化科学研究的协作、创新模式提供领导和支持。首席执行官的长期目标是增加社区参与临床和转化科学研究的能力、主题、实施、评估和传播的发展。

The State of Delaware has an extraordinary opportunity to develop a collaborative and comprehensive approach to clinical and translational science research and education. The DE-CTR Community Engagement and Outreach (CEO) Component of the DE-CTR will create the infrastructure, processes and network for engaging broad and diverse communities throughout the State in both practice-based and community-based translational research. While doing so, it will also create the backbone for integrating multiple developing statewide health promotion and disease prevention activities in clinical and translational science research education and support. In addition, it will incorporate innovative health information technologies for health communication and social marketing that will build interactive research engagement, learning, recruitment and dissemination activities throughout the State. CEO will also collaborate with community-oriented research efforts from the South Carolina Clinical and Translational Research Institute (SCTR) to enhance CEO development and foster interactive dissemination of research to South Carolina and the broader scientific community. An Institute of Medicine (lOM) report. Crossing the Quality Chasm, called for a major campaign to discover effective methods for improving health and reducing health disparities at the national, regional, state and local levels of society. Subsequent lOM reports have emphasized the needs to Accelerate Progress in Obesity Prevention and Explore Integration to Improve Population Health in order to promote healthy behaviors and better reach members of our diverse communities. These calls to action resonate in Delaware, a state that faces the challenge of mitigating the human impact and economic costs associated with relatively high levels of chronic disease and disability. Addressing this challenge effectively will require transformation ofthe process that moves clinical research findings into community and clinical practice settings that serve the needs of diverse populations. DE-CTR institutions will advance this agenda by involving community organizations and their representatives, healthcare providers, clinical practices, and institutional investigators in developing, implementing and evaluating translational research initiatives directed towards improving population health in the region. The CEO Component is a central aspect ofthe DE-CTR that will provide leadership and support for involving community organizations, primary care practices, diverse populations, statewide activities and DECTR investigators in collaborative, innovative models of clinical and translational science research. The long-term goal of CEO is to increase community involvement in the development of capacity, themes, implementation, evaluation and dissemination of clinical and translational science research.